Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | CES2 | O00748 | 3/20 | 0.35 |
| ▸ | CES1 | P23141 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | DAO | P14920 | 1/20 | 0.35 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | AKT1 | P31749 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19085533 | 0.81 | AKT1 (0.36) | ATMAKT1 | |
| SCHEMBL26482446 | 0.81 | TSHR (0.32) | ATMCES1ALDH1A1TSHRMAPK1 | |
| SCHEMBL25107060 | 0.80 | MEN1 (0.35) | ATMMAPTMEN1KMT2AAKT1 | |
| SCHEMBL18105408 | 0.80 | KMT2A (0.35) | ATMCES2CES1ALDH1A1MAPK1 | |
| SCHEMBL18937464 | 0.79 | ATM (0.32) | ATMCES2CES1ALDH1A1TSHR | |
| SCHEMBL19085444 | 0.79 | AKT1 (0.38) | ATMCES2CES1ALDH1A1TSHR | |
| SCHEMBL25784300 | 0.77 | PARP1 (0.46) | MAPK1TDP1POLBMEN1KMT2A | |
| SCHEMBL19300441 | 0.76 | AKT1 (0.38) | ATMCES2CES1ALDH1A1TSHR | |
| SCHEMBL22306048 | 0.76 | C1S (0.44) | ALDH1A1TSHRMAPK1POLBMAPT | |
| SCHEMBL28825945 | 0.74 | CES1 (0.44) | CES2CES1ALDH1A1TSHRDAO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230053347-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-02-23 | — | — | US | disclosed |
| US-10892426-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2021-01-12 | — | — | US | disclosed |
| US-20200152890-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2020-05-14 | — | — | US | disclosed |
| US-9966538-B2 | Compound, light-emitting element and electronic device comprising same | LMS CO., LTD. (KR) | 2018-05-08 | — | — | US | disclosed |
| US-9630983-B2 | Organic electroluminescent material and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2017-04-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200152890-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, LMNB2, RUVBL2 | ATM 2983/4885CES2 718/4885CES1 4139/4885 |
| US-10892426-B2 | Organic electroluminescent materials and devices | OCIAD2, LMNB2, RUVBL2 | ATM 2983/4885CES2 718/4885CES1 4139/4885 |
| US-20230053347-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | SOD1, CLTB, L1CAM | ATM 3636/4885CES2 2879/4885CES1 4855/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.